The nation of Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' request for sensitive data.
The decision was revealed following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesman later explained that the US was requesting biological samples for scientific study and commercial gain while was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further negotiations to reach a agreement agreeable to all parties so the nation's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance openness and responsibility.
According to reports, 16 nations in Africa have so far signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population if a future pandemic arise."
National Interest and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems previously set up via the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our US partners on how future collaboration might be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that talks should continue considering much of the country's Aids initiatives relied on foreign aid.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The halted deal underscores the ongoing debate between receiving vital foreign assistance and protecting national sovereignty in an ever more data-driven world.